About biote Corp
Ticker
info
BTMD
Trading on
info
NASDAQ
ISIN
info
US0906831039
Industry
info
Medical Care Facilities
Sector
info
Healthcare
CEO
info
-
Headquarters
info
1875 W. Walnut Hill Ln #100, Irving, TX, United States, 75038
Employees
info
217
Website
info
biote.com
biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and meet other administrative requirements; inventory management software to monitor pellet inventory; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female. The company was founded in 2012 and is headquartered in Irving, Texas.
Metrics
BasicAdvanced
Market cap
info
$202M
P/E ratio
info
41.33
EPS
info
$0.09
Dividend Yield
info
0.00%
Beta
info
1.07
Forward P/E ratio
info
7.19
EBIDTA
info
$38.9M
Ex dividend date
info
-
Price & volume
Market cap
info
$202M
Average daily volume
info
0.3M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
41.33
Forward P/E
info
7.19
PEG ratio
info
-
Trailing P/E
info
41.33
Price to sales
info
1.03
Price to book
info
2.96
Earnings
EPS
info
$0.09
EPS estimate (current quarter)
info
$0.17
EPS estimate (next quarter)
info
$0.19
EBITDA
info
$38.9M
Revenues (TTM)
info
$197M
Revenues per share (TTM)
info
$5.75
Technicals
Beta
info
1.07
52-week High
info
$8.44
52-week Low
info
$3.04
50-day moving average
info
$4.73
200-day moving average
info
$5.90
Short ratio
info
2.77
Short %
info
3.31%
Management effectiveness
ROE (TTM)
info
0.00%
ROA (TTM)
info
16.96%
Profit margin
info
1.60%
Gross profit margin
info
$139M
Operating margin
info
10.50%
Growth
Quarterly earnings growth (YoY)
info
17.30%
Quarterly revenue growth (YoY)
info
9.00%
Share stats
Outstanding Shares
info
31.5M
Float
info
15.5M
Insiders %
info
27.29%
Institutions %
info
69.36%
Analyst Insights & forecasts
info

100% Buy

0% Hold

0% Sell

Based on information from 6 analysts.

Average price target

info
$7.47
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$0.06
$0.03
300.00%
Q1 • 24Beat
-$0.15
$0.09
266.67%
Q2 • 24Beat
$0.18
$0.20
11.50%
Q3 • 24Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$51.4M
$10.7M
20.83%
Q3 • 24
$49.8M
$3.7M
7.43%
Q4 • 24
3.02%
65.40%
64.32%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$101M
$228M
225.26%
Q3 • 24
$122M
$225M
183.52%
Q4 • 24
20.86%
1.54%
18.53%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$15.6M
$-2M
$-1.8M
$13.6M
Q3 • 24
$12.4M
$-1.3M
$-9.9M
$11.3M
Q4 • 24
20.49%
33.59%
461.88%
16.89%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a biote Corp share?
Collapse

biote Corp shares are currently traded for undefined per share.

How many shares does biote Corp have?
Collapse

biote Corp currently has 31.5M shares.

Does biote Corp pay dividends?
Collapse

No, biote Corp doesn't pay dividends.

What is biote Corp 52 week high?
Collapse

biote Corp 52 week high is $8.44.

What is biote Corp 52 week low?
Collapse

biote Corp 52 week low is $3.04.

What is the 200-day moving average of biote Corp?
Collapse

biote Corp 200-day moving average is $5.90.

Who is biote Corp CEO?
Collapse

The CEO of biote Corp is -.

How many employees biote Corp has?
Collapse

biote Corp has 217 employees.

What is the market cap of biote Corp?
Collapse

The market cap of biote Corp is $202M.

What is the P/E of biote Corp?
Collapse

The current P/E of biote Corp is 41.33.

What is the EPS of biote Corp?
Collapse

The EPS of biote Corp is $0.09.

What is the PEG Ratio of biote Corp?
Collapse

The PEG Ratio of biote Corp is null.

What do analysts say about biote Corp?
Collapse

According to the analysts biote Corp is considered a buy.